Summary by Futu AI
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), was granted 14,112 shares of common stock on May 14, 2024. The transaction, which was completed on the same date, was a grant with a transaction price of $0.00 per share, indicating that the shares were likely awarded as part of a compensation package or incentive plan. Following this transaction, Morrow's direct holdings in the company increased to a total of 30,084 shares of common stock.